Target intelligence / Profile preview

Ribosomal protein S2 pseudogene 46 (RPS2P46)

Target
RPS2P46
Molecular classification
Pseudogene, Other
01

Overview

Ribosomal protein S2 pseudogene 46 is a processed pseudogene whose sequence is derived from the functional RPS2 gene, which encodes a protein component of the small 40S subunit of the ribosome involved in protein synthesis[1][2][3][9]. Pseudogenes like this are considered nonfunctional remnants of gene duplication or retrotransposition events. They are not translated into functional proteins and, in the vast majority of cases, lack any known biological role[5][9]. There is no current evidence linking ribosomal protein S2 pseudogene 46 to human disease, biological pathways, or utility as a drug target or biomarker. This designation is not a misspelling, but represents an entity (a pseudogene) that is generally not considered a molecular target in pharmacology or therapeutic settings. Note: - The number (46) refers to the specific pseudogene among many dispersed in the genome for ribosomal protein S2; there may be dozens identified in genomic studies[9]. - Functional information, druggability, and biological relevance pertain to the parent gene RPS2, not its numerous pseudogenes. In summary: "Ribosomal protein S2 pseudogene 46" is not a functional or therapeutically relevant target, but rather a genomic pseudogene with no currently described biological function or disease association[5][9].

Other names
RPS2P46ribosomal protein S2 pseudogeneprocessed pseudogene of RPS2

Beyond the preview

Go deeper on Ribosomal protein S2 pseudogene 46 (RPS2P46).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S2 pseudogene 46 (RPS2P46).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call